Recombinant adeno-associated virus (rAAV) is a leading viral vector modality for gene therapy, with several approved treatments and hundreds of ongoing clinical trials. rAAV manufacturing, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback